The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(4-Acryloylpiperazin-1-yl)-6-chloro-1-(2-isopropylphenyl)-7-(3-hydroxynaphthalen-1-yl)quinazolin-2(1H)-one ID: ALA4569344
PubChem CID: 135148898
Max Phase: Preclinical
Molecular Formula: C34H31ClN4O3
Molecular Weight: 579.10
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C=CC(=O)N1CCN(c2nc(=O)n(-c3ccccc3C(C)C)c3cc(-c4cc(O)cc5ccccc45)c(Cl)cc23)CC1
Standard InChI: InChI=1S/C34H31ClN4O3/c1-4-32(41)37-13-15-38(16-14-37)33-28-19-29(35)27(26-18-23(40)17-22-9-5-6-11-25(22)26)20-31(28)39(34(42)36-33)30-12-8-7-10-24(30)21(2)3/h4-12,17-21,40H,1,13-16H2,2-3H3
Standard InChI Key: RFUAPPUJRCCDNG-UHFFFAOYSA-N
Molfile:
RDKit 2D
42 47 0 0 0 0 0 0 0 0999 V2000
20.1147 -27.3016 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5395 -28.1248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5367 -27.2980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8239 -26.8927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2439 -26.8880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9576 -27.2956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6674 -26.8851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6648 -26.0629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8257 -28.5383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1166 -28.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4095 -28.5329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4054 -29.3515 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.1145 -29.7607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8278 -29.3554 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.7022 -28.1208 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.7072 -27.2985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0050 -26.8874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2893 -27.2899 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.2844 -28.1122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9951 -28.5319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5805 -26.8761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5866 -26.0548 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.8657 -27.2794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1569 -26.8656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8215 -26.0714 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
21.5386 -29.7614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5365 -30.5838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2472 -30.9971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9603 -30.5850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9584 -29.7594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2472 -29.3540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8239 -30.9952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1129 -30.5811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8223 -31.8165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3980 -30.1659 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.2395 -26.0701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9437 -25.6565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9367 -24.8417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2262 -24.4396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5213 -24.8581 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5318 -25.6715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3759 -27.2922 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 10 2 0
9 2 2 0
2 3 1 0
3 4 2 0
4 1 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 37 1 0
36 5 1 0
3 5 1 0
9 10 1 0
9 14 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
15 16 1 0
15 20 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
11 15 1 0
18 21 1 0
21 22 2 0
21 23 1 0
23 24 2 0
4 25 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
31 26 1 0
14 26 1 0
27 32 1 0
32 33 1 0
32 34 1 0
13 35 2 0
36 37 1 0
37 38 2 0
38 39 1 0
39 40 2 0
40 41 1 0
41 36 2 0
7 42 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 579.10Molecular Weight (Monoisotopic): 578.2085AlogP: 6.52#Rotatable Bonds: 5Polar Surface Area: 78.67Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: 9.55CX Basic pKa: ┄CX LogP: 6.44CX LogD: 6.44Aromatic Rings: 5Heavy Atoms: 42QED Weighted: 0.24Np Likeness Score: -0.47
References 1. Lanman BA, Allen JR, Allen JG, Amegadzie AK, Ashton KS, Booker SK, Chen JJ, Chen N, Frohn MJ, Goodman G, Kopecky DJ, Liu L, Lopez P, Low JD, Ma V, Minatti AE, Nguyen TT, Nishimura N, Pickrell AJ, Reed AB, Shin Y, Siegmund AC, Tamayo NA, Tegley CM, Walton MC, Wang HL, Wurz RP, Xue M, Yang KC, Achanta P, Bartberger MD, Canon J, Hollis LS, McCarter JD, Mohr C, Rex K, Saiki AY, San Miguel T, Volak LP, Wang KH, Whittington DA, Zech SG, Lipford JR, Cee VJ.. (2020) Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors., 63 (1): [PMID:31820981 ] [10.1021/acs.jmedchem.9b01180 ]